M. Lee

Genome‐defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B‐cell lymphoma

C. Flowers, S. Dave, Michelle J Lee, 2020, Cancer.

Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphoma

C. Flowers, Michelle J Lee, Sharvil P. Patel, 2019, Expert review of hematology.

Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey

I. Lossos, J. Friedberg, J. Leonard, 2022, Blood advances.

Using Informatics Tools to Identify Opportunities for Precision Medicine in Diffuse Large B-cell Lymphoma.

C. Flowers, Michelle J Lee, Sharvil P. Patel, 2019, Clinical lymphoma, myeloma & leukemia.

Important Considerations in the Diagnosis and Management of Post-transplant Lymphoproliferative Disorder

Ashutosh Kumar Singh, Michelle J Lee, J. Koff, 2023, Current Oncology Reports.

Targeted therapies for medulloblastoma: understanding the mechanisms of drug resistance and exploring new peptide-based therapeutics

Michelle J Lee, M. Lee, 2013 .

Discovery of 5-chloro-4-((1-(5-chloropyrimidin-2-yl)piperidin-4-yl)oxy)-1-(2-fluoro-4-(methylsulfonyl)phenyl)pyridin-2(1H)-one (BMS-903452), an antidiabetic clinical candidate targeting GPR119.

Michelle J Lee, S. Griffen, J. Krupinski, 2014, Journal of medicinal chemistry.

Rapid Pharmacokinetic and Biodistribution Studies Using Cholorotoxin-Conjugated Iron Oxide Nanoparticles: A Novel Non-Radioactive Method

Miqin Zhang, R. Ellenbogen, Conroy Sun, 2010, PloS one.